Abstract
The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
Both the incidence of early-stage prostate cancer and rates of PSA screening have declined and coincide with 2012 USPSTF recommendation to omit PSA screening from routine primar...
Screening for Prostate Cancer
For men aged 55 to 69 years, the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one and should include discussion of the potential ...
Screening for Cervical Cancer
The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (A recommendation) The USPSTF recommends screening e...
Screening for Lung Cancer
The USPSTF recommends annual screening for lung cancer with LDCT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within th...
Screening for Colorectal Cancer
Importance: Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52980 persons in the US projected to die of colorectal cancer ...
Publication Info
- Year
- 2012
- Type
- article
- Volume
- 157
- Issue
- 2
- Pages
- 120-134
- Citations
- 2497
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.7326/0003-4819-157-2-201207170-00459
- PMID
- 22801674